Cargando…
Is Incidental Finding the Best Term? A Study of Patients’ Preferences
PURPOSE: There is debate within the genetics community about the optimal term to describe genetic variants unrelated to the test indication, but potentially important for health. Given the lack of consensus and the importance of adopting terminology that promotes effective clinical communication, we...
Autores principales: | Tan, Nina, Amendola, Laura M, O’Daniel, Julianne M., Burt, Amber, Horike-Pyne, Martha J., Boshe, Lacey, Henderson, Gail E., Rini, Christine, Roche M.S., Myra I., Hisama, Fuki M., Burke, Wylie, Wilfond, Benjamin, Jarvik, Gail P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5291803/ https://www.ncbi.nlm.nih.gov/pubmed/27490114 http://dx.doi.org/10.1038/gim.2016.96 |
Ejemplares similares
-
Discordance in selected designee for return of genomic findings in the event of participant death and estate executor
por: Goodman, Jessie L., et al.
Publicado: (2017) -
Genomic Knowledge in the Context of Diagnostic Exome Sequencing: Changes over Time, Persistent Subgroup Differences, and Associations with Psychological Sequencing Outcomes
por: Rini, Christine, et al.
Publicado: (2019) -
A semiquantitative metric for evaluating clinical actionability of incidental or secondary findings from genome-scale sequencing
por: Berg, Jonathan S., et al.
Publicado: (2016) -
The who, what and why of research participants’ intentions to request a broad range of secondary findings in a diagnostic genomic sequencing study
por: Rini, Christine, et al.
Publicado: (2017) -
Factors influencing NCGENES research participants’ requests for non-medically actionable secondary findings
por: Roche, Myra I., et al.
Publicado: (2018)